• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Investigation of risk factors for invasive pulmonary aspergillosis among patients with COVID-19

tetano

Editor, Senior Moderator
Sci Rep


. 2024 Sep 2;14(1):20364.
doi: 10.1038/s41598-024-71455-7. Investigation of risk factors for invasive pulmonary aspergillosis among patients with COVID-19

Li Song[SUP] #[/SUP][SUP] 1 [/SUP], Ling Qiu[SUP] #[/SUP][SUP] 2 [/SUP], Gang Wang[SUP] 1 [/SUP], Wenlu Zou[SUP] 1 [/SUP], Shilong Zhang[SUP] 3 4 [/SUP], Lintao Sai[SUP] 5 [/SUP]



Affiliations
Abstract

COVID-19 associated pulmonary aspergillosis (CAPA) had been reported, and raised concern about this secondary infection due to the high mortality. This study aimed to investigate the risk factors for CAPA. The enrolled 114 COVID-19 patients were further divided into CAPA group and non-CAPA group. Demographic characteristics, underlying diseases, laboratory parameters and therapeutic schedule between the two groups were compared to identify the independent risk factors for CAPA by univariate analysis and multivariable logistic regression analysis. Sensitivity and specificity of independent risk factors were confirmed by receiver operating characteristic (ROC) curve analysis. Univariate analysis showed that renal transplant, IL-6 and CRP levels, decreased CD4 + T cell and CD8 + T cell, duration of antibiotics therapy, and prolonged mechanical ventilation were risk factors for development of CAPA. These factors were further analyzed by multivariable logistic regression analysis and the results indicated that elevated IL-6 level, decreased CD4 + T cell and prolonged mechanical ventilation could be recognized as independent risk factors for CAPA in COVID-19 patients. Identification of these risk factors is essential to initiate antifungal therapy as soon as possible to improve outcome of patients with CAPA.

Keywords: Aspergillus; COVID-19 associated invasive pulmonary aspergillosis; Risk factors; SARS-CoV-2.

 
Back
Top Bottom